US Food & Drug Administration News: FDA approves a new generic valsartan
Agency prioritizing review of ARB applications to help mitigate shortage of valsartan
SILVER SPRING, MD (STL.News) – The U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers due to the finding that certain lots of valsartan and other ARB medicines contain nitrosamine impurities.